⌘K

Login Start Free

Home/Filings/4/0001193125-25-296986

4//SEC Filing

Warren Lucinda 4

Accession 0001193125-25-296986

CIK 0001645460other

View on SEC.gov Company Profile

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 4:00 PM ET

Size

5.2 KB

Accession

0001193125-25-296986

Insider Transaction Report

Form 4

Period: 2025-09-29

Cue Biopharma, Inc.CUE

CHIEF BUSINESS OFFICER

Transactions

Award
Stock Option (right to buy)
2025-09-29+125,000→ 125,000 total
Exercise: $0.72Exp: 2035-09-28→ Common Stock (125,000 underlying)

Footnotes (1)

[F1]This stock option becomes fully exercisable on the first anniversary of the grant date.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1

filerCIK 0002035620

Filing Metadata

Form type: 4
Filed: Nov 24, 7:00 PM ET
Accepted: Nov 25, 4:00 PM ET
Size: 5.2 KB

View on SEC.gov